Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange 30 Apr 2022
Event Highlights from the 2022 International Conference on Plasmodium vivax Research (ICPvR) 11 Apr 2022
Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration 14 Mar 2022
P. vivax radical cure in Latin America: regional coordination to advance malaria elimination 17 Dec 2021
First real-world use of new protocol for P. vivax case management in Brazil – a Health Ministry and MMV collaboration 08 Oct 2021
New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide 14 Jul 2021
STANDARD G6PD Test receives regulatory approval by the Australian Therapeutic Goods Administration 25 May 2021
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration 08 Jan 2021
29 May 2024 2024 Geneva Health Forum This year's GHF will focus on health and the environment with a day dedicated to the elimination of malaria. 27 - 29 May 2024 Geneva, Switzerland
12 Feb 2025 9th International Conference on Plasmodium vivax Research (ICPvR) 2025 The 9th International Conference on Plasmodium vivaxResearch will take place in Puducherry, India from 12th to 14th February 2025. 12 - 14 Feb 2025 Puducherry, India